{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:52:07Z","timestamp":1790812327554,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.coph.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T04:32:28Z","timestamp":1527827548000},"page":"129-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The role of magnetic resonance angiography in peripheral artery disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Zaid H","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Lerakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.05.008_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1358863X9700200310","article-title":"The epidemiology of peripheral arterial disease: importance of identifying the population at risk","volume":"2","author":"Criqui","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.coph.2018.05.008_bib0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"Hirsch","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ro.2014.10.011","article-title":"Screening for peripheral artery disease","volume":"50","author":"Sorensen","year":"2015","journal-title":"Semin Roentgenol"},{"key":"10.1016\/j.coph.2018.05.008_bib0020","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary","volume":"22","author":"Gerhard-Herman","year":"2017","journal-title":"Vasc Med"},{"key":"10.1016\/j.coph.2018.05.008_bib0025","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1007\/s00330-013-2933-8","article-title":"Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischaemia and intermittent claudication: systematic review and meta-analysis","volume":"23","author":"Jens","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-153-5-201009070-00007","article-title":"Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease","volume":"153","author":"Menke","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coph.2018.05.008_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.rli.0000129467.71381.8a","article-title":"Comparison of contrast-enhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss","volume":"39","author":"Leiner","year":"2004","journal-title":"Invest Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.39217.473275.55","article-title":"Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review","volume":"334","author":"Collins","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2018.05.008_bib0045","series-title":"Magnetic Resonance Angiography: Principles and Applications","author":"Carr","year":"2012"},{"key":"10.1016\/j.coph.2018.05.008_bib0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2214\/AJR.07.3359","article-title":"Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial","volume":"190","author":"Ouwendijk","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.coph.2018.05.008_bib0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1126\/science.4059917","article-title":"Projective imaging of pulsatile flow with magnetic resonance","volume":"230","author":"Wedeen","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.coph.2018.05.008_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiology.191.1.8134563","article-title":"Gadolinium-enhanced MR aortography","volume":"191","author":"Prince","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.coph.2018.05.008_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25 years of contrast-enhanced MRI: developments, current challenges and future perspectives","volume":"33","author":"Lohrke","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2018.05.008_bib0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCIMAGING.111.970814","article-title":"Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions","volume":"5","author":"Pollak","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.coph.2018.05.008_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mric.2008.12.005","article-title":"Neurovascular imaging at 1.5 tesla versus 3.0 tesla","volume":"17","author":"Huang","year":"2009","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.coph.2018.05.008_bib0080","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1148\/rg.275065204","article-title":"Body MR imaging at 3.0T: understanding the opportunities and challenges","volume":"27","author":"Barth","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.coph.2018.05.008_bib0085","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1148\/radiol.2482071505","article-title":"High-spatial-resolution lower extremity MR angiography at 3.0T: contrast agent dose comparison study","volume":"248","author":"Habibi","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.coph.2018.05.008_bib0090","article-title":"Advances in MR angiography with 7T MRI: from microvascular imaging to functional angiography","author":"Park","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.coph.2018.05.008_bib0095","unstructured":"Communication, F.D.S. 2017; Available from: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm455386.htm."},{"key":"10.1016\/j.coph.2018.05.008_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejrad.2008.01.025","article-title":"Extracellular gadolinium contrast agents: differences in stability","volume":"66","author":"Morcos","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S1968","article-title":"Gadofosveset-enhanced magnetic resonance angiography","volume":"4","author":"Goyen","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"Suppl 2","key":"10.1016\/j.coph.2018.05.008_bib0110","article-title":"Vasovist-enhanced MR angiography","volume":"16","author":"Goyen","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/RLI.0b013e318063c635","article-title":"First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine","volume":"42","author":"Klessen","year":"2007","journal-title":"Invest Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1148\/radiol.2492072033","article-title":"Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA","volume":"249","author":"Hadizadeh","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.coph.2018.05.008_bib0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.mric.2017.06.007","article-title":"Gadolinium deposition and chronic toxicity","volume":"25","author":"Ramalho","year":"2017","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.coph.2018.05.008_bib0130","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium\u2014a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.coph.2018.05.008_bib0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ki.5002338","article-title":"Gadolinium and nephrogenic systemic fibrosis","volume":"72","author":"Grobner","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.coph.2018.05.008_bib0140","unstructured":"Agency, T.E.M. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2017\/07\/WC500231829.pdf. 2017; Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2017\/07\/WC500231829.pdf."},{"key":"10.1016\/j.coph.2018.05.008_bib0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1532-429X-13-19","article-title":"Magnetic resonance angiography: current status and future directions","volume":"13","author":"Hartung","year":"2011","journal-title":"J Cardiovasc Magn Resonance"},{"key":"10.1016\/j.coph.2018.05.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2481071497","article-title":"Nonenhanced MR angiography","volume":"248","author":"Miyazaki","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.coph.2018.05.008_bib0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jmri.22049","article-title":"T1-weighted-SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience","volume":"31","author":"Mihai","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.coph.2018.05.008_bib0160","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mrm.22287","article-title":"Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility","volume":"63","author":"Edelman","year":"2010","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.coph.2018.05.008_bib0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s003300050642","article-title":"Phase-contrast MR angiography of peripheral arteries: technique and clinical application","volume":"9","author":"Reimer","year":"1999","journal-title":"Eur Radiol"},{"key":"10.1016\/j.coph.2018.05.008_bib0170","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/jmri.24266","article-title":"Vascular masking for improved unfolding in 2D SENSE-accelerated 3D contrast-enhanced MR angiography","volume":"39","author":"Stinson","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.coph.2018.05.008_bib0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/02841850410006876","article-title":"Volume rendering compared with maximum intensity projection for magnetic resonance angiography measurements of the abdominal aorta","volume":"45","author":"Persson","year":"2004","journal-title":"Acta Radiol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489217301522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T20:38:50Z","timestamp":1530045530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489217301522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S1471489217301522"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.05.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of magnetic resonance angiography in peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}